Expression and clinical significance of E-cad and Gal-3 in laryngeal squamous cell carcinoma

Cheng Zenong,Wu Shiwu,Yu Lan,Song Wenqing,Tao Yisheng
DOI: https://doi.org/10.3870/zgzzhx.2012.04.020
2012-01-01
Abstract:Objective To investigate the expression of E-cadherin(E-cad) and galectin-3(Gal-3) in laryngeal squamous cell carcinoma(LSCC) and the correlation between their expression and clinicopathologic features.Methods The expression of E-cad and Gal-3 protein was detected by immunohistochemistry in 83 specimens of LSCC and 20 specimens of normal laryngeal tissue.Results The positive rates of E-cad and Gal-3 in LSCC were 39.8% and 79.5%;respectively,but 100% and 20.0% in normal laryngeal tissue,with significant differences(P<0.01).In the tumor group,the expressions of E-cad and Gal-3 were associated with the grades of differentiation,lymph node metastasis and pathologic tumor-node-metastasis(pTNM) stages(all P<0.05),but not with age,gender,diameter of tumor and clinical site.And there was a negative correlation between the expression of E-cad and Gal-3.Conclusion The expression of E-cad and Gal-3 may be involved in the initiation of LSCC and closely related to the invasion and development of LSCC;the combined detection of E-cad and Gal-3 has an important role in predicting the invasion and metastasis of LSCC.
What problem does this paper attempt to address?